ESH Video

#ESHBMFS2024 ONE MONTH LEFT TO SUBMIT YOUR ABSTRACT!

July 25, 2024

ESH-EBMT-EHA-IPIG 3rd Translational Research Conference:
BONE MARROW FAILURE AND
LEUKAEMIA PREDISPOSITION SYNDROMES

November 15-17, 2024
Paris, France
#ESHBMFS2024

 

Chairs: Carmem Bonfim (Curitiba), Tim Brümmendorf (Aachen), Antonio Risitano (Naples), Sharon Savage (Bethesda)

Scientific Committee: Beatrice Drexler (Basel), Carlo Dufour (Genova), Morag Griffin (Leeds), Régis Peffault de Latour (Paris)

With the support of the Severe Aplastic Anaemia Working Party of the EBMT, the EHA SWG on Granulocyte and Bone Marrow Failures and the International PNH Interest Group.

 


 

ONE MONTH LEFT TO SUBMIT YOUR ABSTRACT!
Proceed now and get a chance to be a part
of the "Top scoring abstracts" session!

 

 

Abstracts are eligible to be selected for Brief Oral Communications or Poster Presentations;
and to be part of the "Top scoring abstracts" session.
Deadline: August 25th, 2024

 

 


 
 
CONFERENCE'S MAIN SCIENTIFIC TOPICS:
• Stem cell biology
• Inherited predisposition to leukaemia
• Constitutional marrow failure 2
• Constitutional marrow failure 3: telomere biology diseases and others…
• AA & PNH: 1. Pathophysiology and diagnosis
• AA & PNH: 2. CHIP and clonal evolution in BMFS
• Treatment of aplastic anaemia
• Treatment of paroxysmal nocturnal haemoglobinuria
• Expanding areas in BMFS

 


 

On behalf of the European School of Haematology, the Severe Aplastic Anaemia Working Party of the EBMT, the EHA SWG on Granulocyte and Bone Marrow Failures and the International PNH Interest Group, we are pleased to invite you to the 3rd ESH-EBMT-EHA-IPIG Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes.


ABOUT THE CONFERENCE:

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure and Leukaemia Predisposition Syndromes will be of particular value for clinicians and non- clinical scientists, M.D. and Ph.D. of all ages interested in the biology, pathophysiology, diagnosis and treatment of bone marrow failure syndromes (BMFS) and leukaemia predisposition syndromes. We will not only discuss the standard of care in acquired but also inherited BMFS occurring in adult and paediatric patients, but particularly focus on new underlying principles and evolving new treatment strategies.

Read more...

 

 


 

ESH SCHOLARSHIP FUND:
SCHOLARSHIPS ARE AVAILABLE!


This Call for Applications is made thanks to a funding support from:



 

 
The present Call for Applications may be of interest to:
- fully trained biologists and clinicians
- senior clinical residents and PhD candidates
There is no geographical restriction

Deadline for applications: September 17th, 2024


 
Application form to be sent to: conferences@esh.org

 

The ESH Scholarship Fund is a multi-sponsored project designed to support access to new biological and clinical data in the context of lifelong learning in Haematology.
- ESH independently ensures all scientific peer review and selection procedures.
- ESH is also independently responsible for all administrative aspects of the Fund.

 


 

REGISTRATION

PRELIMINARY SCIENTIFIC PROGRAMME

FACULTY MEMBERS

MORE INFORMATION

 


 

With the support of*:


Major Conference Partners
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.